Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chubb
McKesson
Dow
Chinese Patent Office
AstraZeneca
Fuji
Accenture
McKinsey

Generated: November 15, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Dr Reddys Labs Inc

« Back to Dashboard

Dr Reddys Labs Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Dr Reddys Labs Inc escitalopram oxalate 077798 5MG TABLET; ORAL
Dr Reddys Labs Inc rosiglitazone maleate 076748 4MG TABLET; ORAL
Dr Reddys Labs Inc escitalopram oxalate 077798 20MG TABLET; ORAL
Dr Reddys Labs Inc escitalopram oxalate 077798 10MG TABLET; ORAL
Dr Reddys Labs Inc rosiglitazone maleate 076748 8MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Covington
Cipla
Johnson and Johnson
Teva
Mallinckrodt
McKinsey
Chinese Patent Office
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.